相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
Afeez Adekunle Ishola et al.
CANCER RESEARCH (2022)
CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis
Cao Gao et al.
CELL BIOLOGY AND TOXICOLOGY (2022)
Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway
Yan-Jie Xu et al.
CELLULAR SIGNALLING (2021)
The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy
Zhixiao Fang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1
Jianru Yang et al.
FRONTIERS IN ONCOLOGY (2021)
Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma
Guili Xu et al.
CANCER CELL INTERNATIONAL (2021)
circ-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 Axis
Zhipeng Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma
Arantxa Carrasco-Leon et al.
CANCERS (2021)
Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1
Junshang Ge et al.
CANCER RESEARCH (2021)
Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives
Huan-Huan Chen et al.
FRONTIERS IN ONCOLOGY (2021)
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
Dima Hattab et al.
PHARMACEUTICS (2021)
circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma
JunFeng Wang et al.
CELL DEATH & DISEASE (2020)
Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion
Li Li et al.
CANCER CELL INTERNATIONAL (2020)
Plasma Level of Circular RNA hsa_circ_0000190 Correlates with Tumor Progression and Poor Treatment Response in Advanced Lung Cancers
Yung-Hung Luo et al.
CANCERS (2020)
Circular RNA circ-CPA4/let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)
Weijun Hong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles
Jacob J. Orme et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The Resistance Mechanisms of Lung Cancer Immunotherapy
Fen Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
Muhammad Khan et al.
FRONTIERS IN IMMUNOLOGY (2020)
CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway
Yashu Feng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Lanlan Gao et al.
EBIOMEDICINE (2019)
Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
Min Su et al.
MOLECULAR CANCER (2019)
Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Anqi Lin et al.
MOLECULAR CANCER (2019)
Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities
Antonio Santaniello et al.
CANCERS (2019)
Increased expression of circRNA_102231 in lung cancer and its clinical significance
Liang Zong et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway
Jun Wan et al.
ONCOLOGY REPORTS (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
Robert J. Torphy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer
Zhao Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Evaluation of CD43 expression in non-hematopoietic malignancies
Bjorn H. Batdorf et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
miR-142-5p regulates tumor cell PD-Ll expression and enhances anti-tumor immunity
Long Jia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer
Shijun Chen et al.
CLINICA CHIMICA ACTA (2017)
The Association Between Tumor Epidermal Growth Factor Receptor (EGFR) Mutation and Multiple Primary Malignancies in Patients With Adenocarcinoma of the Lungs
Yung-Hung Luo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins
Marianne C. Kramer et al.
GENES & DEVELOPMENT (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
Chee-Seng Tan et al.
LANCET ONCOLOGY (2015)
Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
Yuh-Min Chen
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2013)
Non-Small Cell Lung Cancer
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Tumor Immunotherapy Directed at PD-1
Antoni Ribas
NEW ENGLAND JOURNAL OF MEDICINE (2012)
分享论文
